Cancer drugs covered by WPA

Phone Us


Targeted/Biological therapies, when used for their European Medicines Agency (EMEA) therapeutic indication, are covered by WPA, when these are not readily available to you as an NHS patient

In the past, any medication used to treat cancer was regarded as chemotherapy. However, over the last 20 years, new types of medication that work in a different way to chemotherapy have been introduced.

These new types of medication are known as Targeted/Biological therapies. This is because they are designed to target and disrupt one or more of the biological processes that cancerous cells use to grow and reproduce. In contrast, chemotherapy medications are designed to have a poisonous effect on cancerous cells.

Targeted/Biological therapies, when used for their European Medicines Agency (EMA) therapeutic indication, are covered by WPA, when these are not readily available to you as an NHS patient, but some group schemes may vary.

If you visit your Cancer Specialist and are prescribed one of these Targeted drugs, your Oncologist will be able to advise you of their availability on the NHS or the Cancer Drugs Fund (England). You can check whether your drug treatment is licensed for your cancer on www.ema.europa.eu and/or the NHS status of your drug on www.nice.org.uk, www.england.nhs.uk or www.scottishmedicines.org.uk

We have provided a list of brand and generic names of commonly used Targeted/Biological therapies below; however, if you are not sure whether your treatment includes a Targeted/Biological therapy please contact WPA.

If you have any questions regarding the provision of benefit for any aspects of your treatment, please contact WPA to discuss the cover that can be provided prior to any treatment.

Please click here for examples of the Cancer Care available through WPA Policies.


Last updated: 01/09/2016


Brand name Generic name   Brand name Generic name
Avastin Bevacizumab   Adcetris Brentuximab Vedotin
Afinitor Everolimus   Bexxar Iodine 133-Tositumomab
Bosulif Bosutinib   Caprelsa Vandetanib
Cimzia Certolizumab   Cyramza Ramucirumab
Darzalex Daratumumab   Entyvio Vedolizumab
Erbitux Cetuximab   Eylea Aflibercept
Gazyvaro Obinutuzumab   Giotrif Afatinib
Glivec Imatinib   Herceptin Trastuzumab
Humira Adalimumab   Imbruvica Ibrutinib
Imlygic Talimogene Laherparepvec   Imnovid Pomalidomide
Inylta Axitinib   Kadcyla Trastuzumab Emtansine
Keytruda Pembrolizumab   Kyprolis Carfilzomib
Lenvima Lenvatinib   Lonsurf Trifluridine/Tipiracil
Lucentis Ranibizumab   Lynparza Olaparib
MabCampath Alemtuzumab   Mabthera Rituximab
Macugen Pegaptanib   Mekinist Trametinib
Mylotarg Gemtuzumab   Nexavar Sorafenib
Opdivo Nivolumab   Perjeta Pertuzumab
Pomalyst Pomalidomide   Prolia Denosumab
Raptiva Efalizumab   Remicade Infliximab
Revlimid Lenalidomide   RoActemra Tocilizumab
Soliris Eculizumab   Sprycel Dasatinib
Stivarga Regorafenib   Sutent Sunitinib
Tafinlar Dabrafenib   Tagrisso Osimertinib
Tarceva Erlotinib   Tasigna Nilotinib
Tyverb Lapatanib   Vargatef Nintedanib
Vectibix Panitumumab   Velcade Bortezomib
Votrient Pazopanib   Votubia Everolimus
Yervoy Ipilimumab   Xalkori Crizotinib
Xgeva Denosumab   Xofigo Radium 223
Xtandi Enzalutamide   Zaltrap Aflibercept
Zelboraf Vemurafenib   Zevalin Ibritumomab
Zytiga Abiraterone  


Please click here to view useful medical website links.